top of page
Referring Provider Forms
Glassia® (alpha-1 proteinase inhib)
Ilaris® (canakinumab)
Infliximab
Krystexxa® (pegloticase)
Leqembi® (lecanemab-irmb)
Lumizyme® (alglucosidase alfa)
Nulojix® (belatacept)
Ocrevus® (ocrelizumab)
Orencia® (abatacept)
Quzyttir® (cetirizine hydrochloride)
Rystiggo® (rozanolixizumab-noli)
Simponi Aria® (golimumab)
Soliris® (eculizumab)
Stelara® (Gastro)
Subcutaneous Immunoglobulin
Tezspire™ (tezepelumab)
Tysabri® (natalizumab)
Ultomiris® (ravulizumab-cwvz)
Vyepti® (eptinezumab-jjmr)
Vyvgart® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc)
Fasenra® (benralizumab)
IVIG Immunoglobulin Therapy
Ilumya® (tildrakizumab)
Kisunla™ (donanemab-azbt)
Lemtrada® (alemtuzumab)
Leqvio® Injection (inclisiran)
Nucala® (mepolizumab)
Ocrevus Zunovo™ (ocrelizumab and hyaluronidase-ocsq)
Omvoh® (mirikizumab-mrkz)
Prolastin®-C (alpha-1 proteinase inhib)
Rituximab
Saphnelo™ (anifrolumab-fnia)
Skyrizi® (risankizumab-rzaa)
Spevigo® (spesolimab-sbzo)
Stelara® (Rheum/Derm)
Tepezza® (teprotumumab)
Tremfya® (guselkumab)
Tzield® (teplizumab-mzwv)
Uplizna® (inebilizumab-cdon)
Vyvgart® (efgartigimod alfa-fcab)
Xolair® (omalizumab)
bottom of page